Glimpse Group Inc

For the period ended Dec 31, 2024. Filed Feb 13, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2024 · Filed Feb 13, 2025

BTLN$3.67+4.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED DECEMBER 31, 2024

Common Stock · Additional · Accumulated
	Shares	Amount	Paid-In Capital	Deficit	Total
Balance as of October 1, 2024	18,166,217	$18,166	$74,926,319	$(64,053,465)	$10,891,020
Common stock and stock option based compensation expense	8,000	8	28,037	-	28,045
Stock option-based board of directors expense	-	-	12,459	-	12,459
Common stock issued for exercise of options	7,789	8	(8)	-	-
Common stock issued in Securities Purchase Agreement and prefunded warrants, net	1,990,000	1,990	6,783,562	-	6,785,552
Common stock issued for exercise of warrants	100,000	100	174,900	-	175,000
Net income	-	-	-	25,872	25,872
Balance as of December 31, 2024	20,272,006	$20,272	$81,925,269	$(64,027,593)	$17,917,948

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED DECEMBER 31, 2024

Common Stock · Additional · Accumulated
	Shares	Amount	Paid-In Capital	Deficit	Total
Balance as of July 1, 2024	18,158,217	$18,158	$74,559,600	$(63,039,273)	$11,538,485
Common stock and stock option based compensation expense	16,000	16	382,296	-	382,312
Stock option-based board of directors expense	-	-	24,919	-	24,919
Common stock issued for exercise of options	7,789	8	(8)	-	-
Common stock issued in Securities Purchase Agreement and prefunded warrants, net	1,990,000	1,990	6,783,562	-	6,785,552
Common stock issued for exercise of warrants	100,000	100	174,900	-	175,000
Net loss	-	-	-	(988,320)	(988,320)
Balance as of December 31, 2024	20,272,006	$20,272	$81,925,269	$(64,027,593)	$17,917,948

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED DECEMBER 31, 2023

Common Stock · Additional · Accumulated
	Shares	Amount	Paid-In Capital	Deficit	Total
Balance as of October 1, 2023	14,812,518	$14,813	$68,801,845	$(56,764,421)	$12,052,237
Common stock issued in Securities Purchase Agreement, net	1,885,715	1,886	2,966,615	-	2,968,501
Common stock issued to vendors for compensation	17,671	18	46,328	-	46,346
Stock based compensation expense	6,242	6	399,248	-	399,254
Stock option-based board of directors expense	-	-	69,174	-	69,174
Net loss	-	-	-	(738,367)	(738,367)
Balance as of December 31, 2023	16,722,146	$16,723	$72,283,210	$(57,502,788)	$14,797,145

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED DECEMBER 31, 2023

Common Stock · Additional · Accumulated
	Shares	Amount	Paid-In Capital	Deficit	Total
Balance as of July 1, 2023	14,701,929	$14,702	$67,854,108	$(56,644,978)	$11,223,832
Common stock issued in Securities Purchase Agreement, net	1,885,715	1,886	2,966,615	-	2,968,501
Common stock issued to vendors for compensation	28,571	29	73,253	-	73,282
Common stock issued for exercise of options	8,819	9	(9)	-	-
Common stock issued to satisfy contingent acquisition obligations	35,714	36	127,109	-	127,145
Stock based compensation expense	61,398	61	1,118,859	-	1,118,920
Stock option-based board of directors expense	-	-	143,275	-	143,275
Net loss	-	-	-	(857,810)	(857,810)
Balance as of December 31, 2023	16,722,146	$16,723	$72,283,210	$(57,502,788)	$14,797,145

The accompanying notes are an integral part of these consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.